NCT00578968 - Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Chronic Obstructive Pulmonary DiseaseCOPD

Interventions

DRUG

Tiotropium

Participants received once daily Spiriva capsules for oral inhalation: 18 mcg tiotropium powder, for use with HandiHaler device.

DRUG

Placebo

Participants randomized to this arm received a once daily oral inhalation of placebo powder to match the standard active comparator dose, using the HandiHaler device.

Trial Locations (1)

55905

Mayo Clinic, Rochester